Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ABEO compared with ELUT: revenue, margins and what each company keeps, and the suppliers and customers both name
ABEO
Abeona Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
ELUT
Elutia Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ABEO
Abeona Therapeutics Inc.
vs
ELUT
Elutia Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
ABEO: latest quarter is a loss; flow not drawable. ELUT: latest quarter is a loss; flow not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ABEO, solid
ELUT, dashed
ABEO
Abeona Therapeutics Inc.
Change
4.34
▼
−4.83%
· post 4.34
Mkt cap
$248.8M
Revenue
$11M
Q2 FY26
ELUT
Elutia Inc.
Change
0.84
▲
+2.89%
· post 0.86
Closed
Oct 30 '26
Mkt cap
$37.1M
Revenue
$2M
Q2 FY26
vs
Compare
Closed
Oct 30 '26
ABEO
Abeona Therapeutics Inc.
vs
ELUT
Elutia Inc.
4.34
▼
−4.83%
post 4.34
Price
0.84
▲
+2.89%
post 0.86
$248.8M
Mkt cap
$37.1M
Q2 FY26
$11M
Revenue
$2M
Q2 FY26
Change
Change
ABEO
4.34
▼
−4.83%
vs
ELUT
0.84
▲
+2.89%
Closed
Oct 30 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ABEO
1
TSHA
Taysha Gene Therapies
customer
Shared
0
No shared counterparties.
Only ELUT
9
MDT
Medtronic Sofamor Danek USA
customer
BSX
Boston Scientific
customer
—
Berkeley
unlisted
supplier
—
Cook
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
unlisted
supplier
5 more · ELUT chain
›